Download presentation
Presentation is loading. Please wait.
Published byMaximillian Stevenson Modified over 6 years ago
1
Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial Christopher Parrish, Curly T.C.M. Morris, Cathy D. Williams, David A. Cairns, Jamie Cavenagh, John A. Snowden, John Ashcroft, Jim Cavet, Hannah Hunter, Jenny M. Bird, Anna Chalmers, Julia M. Brown, Kwee Yong, Steve Schey, Sally Chown, Gordon Cook Biology of Blood and Marrow Transplantation Volume 22, Issue 6, Pages (June 2016) DOI: /j.bbmt Copyright © 2016 The American Society for Blood and Marrow Transplantation Terms and Conditions
2
Figure 1 Trial CONSORT Diagram. A full consort diagram for the trial is published (Cook et al. [17]). SD indicates stable disease; PD, progressive disease. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2016 The American Society for Blood and Marrow Transplantation Terms and Conditions
3
Figure 2 Mobilization regimens employed and percentage of mobilization attempts leading to successful PBSC harvest at first, second, and third mobilization attempts. Error bars show 95% confidence intervals. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2016 The American Society for Blood and Marrow Transplantation Terms and Conditions
4
Figure 3 Kaplan-Meier curves after ASCT for patients receiving PBSC harvested before trial entry (PBSC1), reharvested in the trial (PBSC2), and a combination of both sources (PBSCMix). Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2016 The American Society for Blood and Marrow Transplantation Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.